HORIZON EUROPE
Europeo
Specific Challenge:Photonic technologies for health applications is a very promising field, where the EU has produced significant results during the past decades; however, industrialization is still lagging behind. The challenges are to develop methods that provide the clinicians with photonics enabled tools to improve or to assess the successes of therapies and to transform low TRL technologies into robust medical devices answering to clinician needs.
Photonic circuits are typically employed in combination with high performance electronics, micro-optics while the thermal management and the efficient integration of these technologies is accordingly of major importance. The challenge is to create and develop advanced techniques for intimate integration of sub-systems incorporating multiple technologies enabling application across multiple domains.
The European continuous process industries as well as the piecewise manufacturing sector are facing the continuous struggle to keep a leading role in the worldwide competition. The challenge is to deploy photonic sensor technologies for the exact monitoring of process and product parameters so as to optimize those...
ver más
Specific Challenge:Photonic technologies for health applications is a very promising field, where the EU has produced significant results during the past decades; however, industrialization is still lagging behind. The challenges are to develop methods that provide the clinicians with photonics enabled tools to improve or to assess the successes of therapies and to transform low TRL technologies into robust medical devices answering to clinician needs.
Photonic circuits are typically employed in combination with high performance electronics, micro-optics while the thermal management and the efficient integration of these technologies is accordingly of major importance. The challenge is to create and develop advanced techniques for intimate integration of sub-systems incorporating multiple technologies enabling application across multiple domains.
The European continuous process industries as well as the piecewise manufacturing sector are facing the continuous struggle to keep a leading role in the worldwide competition. The challenge is to deploy photonic sensor technologies for the exact monitoring of process and product parameters so as to optimize those processes, saving resources whilst guaranteeing optimum product quality.
Scope:The focus is on the following themes:
Innovation Actions
Photonics devices to support monitoring therapeutic progress: Actions should develop reliable (high sensitivity, specificity and accuracy), safe to operate, cost-effective and fast photonics enabled devices to support assessing the effects of treatments of major diseases like cancer (excluding skin cancer), infectious, degenerative and cardiovascular diseases, including determining individual dispositions (eg methods to assess drug resistance) and monitoring of therapy progress. The feasibility and validity of the proposed approach should already have been validated in clinical settings. A medical equipment manufacturer should drive the action, and physicians/clinicians/surgeons must be closely involved. Validation should take gender specificities into account. Small scale clinical studies should be included, but clinical trials are excluded. Sensor-Based Optimization of Production Processes: Sensor-Based Optimization of Production Processes: Actions should address prototyping, demonstration, optimization and validation in real industry settings of highly advanced smart broadband multimodal photonic sensing solutions operating in the spectral range from the ultraviolet to the far infrared, and intended for improving production process through the monitoring of relevant process and product parameters (e.g. physical, chemical, imaging, geometrical and environmental). The focus is on cost-effective process-integrated solutions that are optimized in terms of speed, quality, and resource efficiency. The solutions should also address embedded pre-processing and suitably interpreting the acquired raw data for the optimization of the processes. The Commission considers that proposals requesting a contribution from the EU between EUR 3 and 6 million would allow these themes to be addressed appropriately. Nevertheless this does not preclude submission and selection of proposals requesting other amounts.
Research and Innovation Actions
Photonics System on Chip/ System in Package for optical interconnect applications: Actions should address advanced techniques for the intimate combination of photonic integrated circuit technology with other enabling circuits, devices and mother boards to realise major advances in the capability, performance and complexity of photonic system-on-chip and system-in-package components targeting photonic interconnect applications in the network, datacentre and consumer communication space. A holistic approach from design through to test is required. The targeted component technologies need to have demonstrable performance advantages in terms of speed, energy efficiency, cost and reliability and fit in the system and network architecture roadmaps of vendors. Photonics systems for advanced imaging to support diagnostics driven therapy: Actions should research ground-breaking, reliable (high sensitivity, specificity and accuracy), safe to operate, cost-effective and fast photonics enabled imaging system to support diagnostics during intervention and treatments of major diseases like cancer (excluding skin cancer), infectious, degenerative and cardiovascular diseases. Physicians/clinicians/surgeons and a medical equipment manufacturer must be closely involved from requirement specifications to validation in clinical settings. Validation should take gender specificities into account. Clinical trials are excluded. The Commission considers that proposals requesting a contribution from the EU between EUR 3 and 6 million would allow these themes to be addressed appropriately. Nevertheless this does not preclude submission and selection of proposals requesting other amounts.
Coordination and Support Actions
Fostering careers in photonics: Actions should reach out to STEM graduates/PhD students and young postdocs in order to encourage more of them to pursue a career in photonics. Actions should help make students more industry ready and should provide the appropriate training, encourage innovation and entrepreneurship. Gender issues must also be addressed. The Commission considers that proposals requesting a contribution from the EU between EUR 1 and 1.5 million (for theme i) would allow this to be addressed appropriately. Nevertheless this does not preclude submission and selection of proposals requesting other amounts.
Expected Impact:Proposals should describe how the proposed work will contribute to the listed corresponding expected impacts and include baseline, targets and metrics to measure impact.
Innovation Actions
i. Strengthened Europe industrial competitiveness in the biophotonics related market.
ii. Increased competitiveness of the European production industry and significant contribution to the digitization of European industry.
Research and Innovation Actions
i. European industrial leadership in photonic systems integration and photonic interconnect technologies and applications, enabling the penetration of high-value markets.
ii. Increased European competiveness in the biophotonic areas and more effective medical interventions and treatments.
Coordination and Support Actions
i. More and better prepared professionals in the photonics sector.
Cross-cutting Priorities:GenderContractual Public-Private Partnerships (cPPPs)Photonics
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
1. Eligible countries: described in Annex A of the Work Programme.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
2. Eligibility and admissibility conditions: described in Annex B and Annex C of the Work Programme.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (single-stage call): maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Mult... A small piece of text, which is also relevant for this topic, can be found in the 'Call Summary' under the subheading 'Technologies for Digitising European Industry'.
1. Eligible countries: described in Annex A of the Work Programme.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
2. Eligibility and admissibility conditions: described in Annex B and Annex C of the Work Programme.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (single-stage call): maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
Coordination and Support Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
6. Additional provisions:
Horizon 2020 budget flexibility
Classified information
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply
Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.
8. Additional documents:
1. Introduction WP 2018-20
5. Introduction to Leadership in enabling and industrial technologies (LEITs) WP 2018-20
5i. Information and communication technologies (ICT) WP 2018-20
18. Dissemination, Exploitation and Evaluation WP 2018-20
General annexes to the Work Programme 2018-2020
Legal basis: Horizon 2020 Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions.
Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Open access to research data
The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in Annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.
Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.
Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.
Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs. See the Online Manual.
Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.
The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta